InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Share Price

Current share price for AVR : $15.000 1.37 (10.05%)+

Anteris Technologies Ltd (AVR), an ASX-listed company, is a structural heart company focused on designing, developing, and commercialising medical devices. Founded in Australia, with a presence in Minneapolis, USA (a MedTech hub), it is science-driven, with a team of professionals delivering solutions to structural heart disease patients.

AVR General Information +

ASX Code AVR
Website http://www.anteristech.com
Industry/Sector Health Care Equipment
Market Cap ($M) 228
AVR Share Price $15.000
Day High $15.000
Day Low $14.450
Last Close $13.630
AVR Share Price Movement $1.37 ( 10.05% )
Prices as at 16:40, 24 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Anteris Technologies Ltd (AVR) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Interim 0% 2 Mar 2007 22 Mar 2007 - - -
Final 100% 8 Sep 2006 25 Sep 2006 - - -
Interim 3.5¢ 100% 1 Mar 2006 21 Mar 2006 - - -

See all dividends from Anteris Technologies Ltd (AVR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Anteris Technologies Ltd (AVR) price-sensitive announcements

AVR - Prospectus Supplement and Sales Agreement
Anteris Technologies Global Corp., a company listed on NASDAQ and ASX under the symbol AVR
Anteris Technologies Ltd (AVR)
25 May 2026 | 8:53 AM
AVR - Results for the First Quarter of 2026
Anteris Technologies Ltd announced its financial results for the first quarter ended 31 Ma
Anteris Technologies Ltd (AVR)
13 May 2026 | 8:30 AM
AVR - Quarterly Results Announcement and SEC Form 10-Q
Anteris Technologies Ltd released its quarterly results for the period ending March 31, 20
Anteris Technologies Ltd (AVR)
13 May 2026 | 8:22 AM
AVR - First US Patients Treated in Global Pivotal PARADIGM Trial
Anteris Technologies Ltd has announced that the first U.S. patients have been enrolled and
Anteris Technologies Ltd (AVR)
6 May 2026 | 9:04 AM

Anteris Technologies Ltd (AVR) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Anteris Technologies Ltd (AVR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $228 Notification regarding unquoted securities - AVR 24 Jun 2026 4:35PM $15.000 $15.000 fallen by 0%
Anteris Technologies Ltd (AVR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $228 Application for quotation of securities - AVR 24 Jun 2026 4:30PM $15.000 $15.000 fallen by 0%
Anteris Technologies Ltd (AVR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $228 Change of Director's Interest Notice 22 Jun 2026 9:47AM $13.320 $15.000 risen by 12.61%
Anteris Technologies Ltd (AVR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $228 PARADIGM - French Regulatory Clearance 9 Jun 2026 8:31AM $13.800 $15.000 risen by 8.70%
Anteris Technologies Ltd (AVR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $228 Change of Director's Interest Notice 5 Jun 2026 11:45AM $13.500 $15.000 risen by 11.11%
Anteris Technologies Ltd (AVR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $228 Statement of CDIs on issue - AVR 5 Jun 2026 11:43AM $13.500 $15.000 risen by 11.11%

AVR Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$140.78 -$381.10 -36.40% 0.00 0.00 0.00% 0.0%
2024A -$120.74 -$598.70 38.80% 0.00 0.00 0.00% 0.0%
2023A -$68.89 -$431.50 30.00% 0.00 0.00 0.00% 0.0%

AVR Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Anteris Technologies Ltd (AVR) $207M -0.3635 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear Limited (COH) $7,376M 0.0171 -0.1883 0.0862 18.8460 23.2177 21.3760 3.81% 3.07% 3.28%
Fisher & Paykel Healthcare Corporation Limited (FPH) $18,124M 0.1388 0.1362 0.1883 46.6657 41.0700 34.5615 1.41% 1.50% 1.70%
ResMed Inc. (RMD) $15,444M 0.3087 9.7634 0.0805 185.9697 17.2780 15.9905 1.24% 1.30% 1.37%

AVR Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -4,545.00 0.00
Market 0.29 13.20 1.16 0.69
Sector 0.57 20.50 1.61 2.49

AVR Directors

Name Position Start Date
Mr Wayne Paterson Chief Executive Officer, Managing Director 29 Jan 2024
Mr David St Denis Chief Operating Officer, President, Non-Executive director 6 Mar 2025
Mr Gregory Simon Moss Class I Director, Non-Executive Director 8 Jun 2025
Mr David Roberts Class III Director, Non-Executive Director 8 Jun 2025
Mr Stephen (Steve) Denaro Company Secretary, Non Executive Director 12 May 2026
Mr John Seaberg Non-Executive Chairman, Non-Executive Director 13 Nov 2024
Ms Susan Knight Non-Executive Director 12 May 2026

Anteris Technologies Ltd (AVR) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
2 Jun 2026 KNIGHT, Susan Buy Direct Shares 11,000 $9.293 $102,228.200
31 May 2023 PATERSON, Wayne Issued Direct Shares 4,167 $24.000 $100,008.000
7 Mar 2022 DENARO, Stephen (Steve) Buy Indirect Shares 2,222 $18.020 $40,039.970

See all changes in directors' interest & trades for Anteris Technologies Ltd (AVR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

AVR Calendar of Events

Date Event
26 February 2027 Report (Annual)
26 February 2027 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.